A newly approved oncolytic immunotherapy takes on cancer using a live modified herpes virus

Could an ionic liquid–drug system help solve drug insolubility?

Can lettuce really help biopharmaceuticals turn over a new leaf? Researchers certainly think so.

Sitting Down With... John Talley, Chief Scientific Officer at Euclises Pharmaceuticals, St. Louis, USA.

Grant Lindman is director of Eli Lilly’s global anticounterfeiting operations and is passionate about fighting fake medicines.

Recently, Tim Mackey and colleagues examined the extent to which counterfeit drugs had penetrated global legitimate supply chains.

Single-use technology is ready to lend a helping hand to biomanufacturing, but is the industry ready to turn away from stainless steel?

The EMA fights to reinstate its former executive director – and the FDA’s new leader is still unconfirmed

As the industry makes its video game debut, the big question is: will you prioritize patients over profit? Here’s our big review.

Expedited regulatory approvals bring medicines to market faster – but are they the right drugs?